Choksi Laborator — 360° view

Choksi Laborator, a company in the Healthcare Service Provider industry, reported revenue of ₹12 crore and net profit of ₹0.17 crore for the September 2026 quarter.

Choksi Laborator (BSE: CHOKSILA) closed at ₹180.00 on 20 Nov 2026, up 24.3% over the past year. Its market capitalisation is ₹125 crore and it trades at 68.5 times earnings.

Share price
₹180.00 (20 Nov 2026)
Market cap
₹125 Cr (20 Nov 2026)
P/E
68.51 (20 Nov 2026)
Revenue
₹12 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
9.44% (FY26)
ROE
4.19% (FY26)
Book value
₹37.9 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹227.90 / ₹81.85 (20 Nov 2026)
1-year return
24.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
BSE: CHOKSILA

Incorporated in 1982, Choksi Laboratories Ltd provides contract testing and analytical services.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.